1. Home
  2. RPRX vs AMH Comparison

RPRX vs AMH Comparison

Compare RPRX & AMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • AMH
  • Stock Information
  • Founded
  • RPRX 1996
  • AMH 2012
  • Country
  • RPRX United States
  • AMH United States
  • Employees
  • RPRX N/A
  • AMH N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • AMH Real Estate Investment Trusts
  • Sector
  • RPRX Health Care
  • AMH Real Estate
  • Exchange
  • RPRX Nasdaq
  • AMH Nasdaq
  • Market Cap
  • RPRX 13.9B
  • AMH 14.4B
  • IPO Year
  • RPRX 2020
  • AMH 2013
  • Fundamental
  • Price
  • RPRX $37.85
  • AMH $34.50
  • Analyst Decision
  • RPRX Strong Buy
  • AMH Buy
  • Analyst Count
  • RPRX 4
  • AMH 17
  • Target Price
  • RPRX $46.75
  • AMH $40.85
  • AVG Volume (30 Days)
  • RPRX 2.5M
  • AMH 2.1M
  • Earning Date
  • RPRX 08-06-2025
  • AMH 07-31-2025
  • Dividend Yield
  • RPRX 2.38%
  • AMH 3.45%
  • EPS Growth
  • RPRX 43.84
  • AMH 15.35
  • EPS
  • RPRX 2.16
  • AMH 1.11
  • Revenue
  • RPRX $2,304,578,000.00
  • AMH $1,798,427,000.00
  • Revenue This Year
  • RPRX $28.60
  • AMH $7.36
  • Revenue Next Year
  • RPRX $8.07
  • AMH $4.85
  • P/E Ratio
  • RPRX $17.14
  • AMH $31.30
  • Revenue Growth
  • RPRX 2.99
  • AMH 7.21
  • 52 Week Low
  • RPRX $24.05
  • AMH $31.68
  • 52 Week High
  • RPRX $38.00
  • AMH $41.41
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 57.95
  • AMH 39.02
  • Support Level
  • RPRX $36.27
  • AMH $34.45
  • Resistance Level
  • RPRX $38.00
  • AMH $36.10
  • Average True Range (ATR)
  • RPRX 0.68
  • AMH 0.70
  • MACD
  • RPRX -0.02
  • AMH -0.09
  • Stochastic Oscillator
  • RPRX 64.97
  • AMH 8.71

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

Share on Social Networks: